Inteliview
Log inSign up
IPO Tracker
Tarsier Pharma Ltd.

Tarsier Pharma Ltd.

Tarsier Pharma Ltd.

USPricing
Valuation$35M
Original Target2026-04-21 (Date under review)
Sector--
Exchange--
RELATED IPOS
Picard Medical, Inc.
Picard Medical, Inc.Picard Medical, Inc.US · --
HealthLynked Corp
HealthLynked CorpHealthLynked CorpUS · --
Onconetix, Inc.
Onconetix, Inc.Onconetix, Inc.US · --
A
Aperture ACAperture ACUS · --
Next Bridge Hydrocarbons, Inc.
Next Bridge Hydrocarbons, Inc.Next Bridge Hydrocarbons, Inc.US · --
E
EUPEC International Group LtdEUPEC International Group LtdUS · --
FAQ

When is the Tarsier Pharma Ltd. IPO expected?

The Tarsier Pharma Ltd. IPO is currently in the Pricing stage. The originally expected date was 2026-04-21 and the process is ongoing. Timelines may change based on market conditions.

What is Tarsier Pharma Ltd.'s valuation?

Tarsier Pharma Ltd.'s estimated valuation is approximately $35M. The final valuation will depend on IPO pricing and market demand.

Can retail investors participate in the Tarsier Pharma Ltd. IPO?

U.S. IPOs are typically allocated to institutional investors first. Retail investors can purchase shares on NYSE/NASDAQ after listing. Some brokerages offer IPO access programs for pre-IPO allocation.